SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-005210
Filing Date
2019-03-29
Accepted
2019-03-29 13:39:38
Documents
6
Period of Report
2019-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k032719_immucellcorp.htm 8-K 33269
2 UNDERWRITING AGREEMENT BETWEEN THE COMPANY AND CRAIG-HALLUM CAPITAL GROUP LLC, D f8k032719ex1-1_immucell.htm EX-1.1 251135
3 OPINION OF PIERCE ATWOOD LLP f8k032719ex5-1_immucell.htm EX-5.1 9221
4 PRESS RELEASE OF IMMUCELL CORPORATION, DATED MARCH 26, 2019 f8k032719ex99-1_immucell.htm EX-99.1 12623
5 PRESS RELEASE OF IMMUCELL CORPORATION, DATED MARCH 27, 2019 f8k032719ex99-2_immucell.htm EX-99.2 12785
6 PRESS RELEASE OF IMMUCELL CORPORATION, DATED MARCH 29, 2019 f8k032719ex99-3_immucell.htm EX-99.3 16657
  Complete submission text file 0001213900-19-005210.txt   336820
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 19715426
SIC: 2835 In Vitro & In Vivo Diagnostic Substances